Banco Bilbao Vizcaya Argentaria posted €2.96 billion in first-quarter net profit, an 11% increase from the prior-year period, and announced a fresh tranche of share repurchases as the Spanish lender continues to distribute capital at a pace that stands out among European peers navigating stricter Basel IV requirements.

The earnings beat came from resilient net interest income in Mexico and Spain, where BBVA's retail lending margins held firm despite European Central Bank rate cuts beginning in June 2024. The bank's cost-of-risk ratio ticked down to 0.89%, below the 0.94% analysts had penciled in, suggesting credit quality in its Latin American book remains stable even as AMLO-era fiscal expansion fades. Return on tangible equity reached 18.2% for the quarter, sustaining the mid-teens profile BBVA has maintained since mid-2023. The new buyback tranche was not sized in the release, but the bank confirmed it remains on track to distribute more than €5 billion to shareholders across 2025, split between dividends and opportunistic repurchases.

This matters because BBVA is one of the few large European banks defending an aggressive capital return posture while peer institutions hoard reserves ahead of Basel IV implementation in January 2026. The bank's CET1 ratio stood at 13.1% at quarter-end, comfortably above its 11.5% regulatory minimum but below the 14% cushion that peers like Santander and BNP Paribas are targeting. BBVA's thesis rests on two assumptions: that its Latin American franchise—particularly Mexico, which contributes nearly half of group profit—will continue generating returns above 20% on equity, and that Spanish regulators will not impose material Pillar 2 add-ons during the next supervisory review cycle in Q3 2025. Both assumptions are testable within six months.

The counter-argument is visible in the bank's loan-loss reserves. Provisions rose 7% quarter-over-quarter, driven by a modest uptick in Stage 2 exposures in Turkey, where BBVA's subsidiary Garanti BBVA holds €28 billion in risk-weighted assets. Turkey's central bank has kept policy rates above 50% to manage inflation, squeezing corporate borrowers and nudging more credits into the watchlist category. If Turkish inflation does not materially decline by mid-year, BBVA may face a choice between defending its capital return guidance and building a larger buffer for potential Stage 3 migrations. The bank has not yet revised its full-year €11.5 billion revenue target, but Turkish exposure is the line item family offices should monitor for earnings volatility in H2.

Allocators should watch for three near-term events: BBVA's Investor Day on May 14, where management will update its three-year shareholder return framework; the ECB's supervisory capital review letters, expected in early June, which will clarify whether Spanish banks face higher Pillar 2 requirements; and Garanti BBVA's standalone Q2 results in late July, which will show whether the Turkish book is stabilizing or deteriorating. The bank's share price has traded in a narrow €10.80–€11.40 band since February, suggesting the market is waiting for clarity on at least one of those variables before repricing the equity.

BBVA's capital return is a conviction call on two geographies—Mexico and Spain—that are both mid-cycle, not early-cycle, and on a regulatory environment that may tighten before it eases. The €5 billion payout promise is the fulcrum; if it holds, the stock re-rates toward 12x forward earnings. If it bends, the multiple compresses to peer average, and the buyback thesis unwinds. The next twelve weeks will clarify which outcome is already priced.